News & Analysis on Clinical Trial Services & Contract Research And Development
Contract research company, EpiStem have announced the successful installation of an automated imaging system that now enables the firm to expand the range and throughput of its services in immunohistochemistry (IHC) and histometric analysis.
Medical innovations company BTG, continued its progress on the strategy it implemented last May by revealing its operating highlights that has seen six new programmes added to its product pipeline.
AstraZeneca sought to reassure investors this week by providing an update on progress made in strengthening its product pipeline, a worry for industry analysts who believe its existing products cannot underpin earnings growth for much longer.
Scientists believe they have made a breakthrough in the fight against HIV drug resistance by developing a drug that is the first in a new class of HIV drug candidates called Maturation Inhibitors.
Applied Biosystems (AB) make available a wider range of microRNA assays, expanding the selection to 300 individual assays that are ideal for cell differentiation, developmental biology, stem cell and cancer research.